
LINK . SPRINGER . COM {
}
Title:
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer | Cancer Immunology, Immunotherapy
Description:
Pancreatic ductal adenocarcinoma is a leading cause of cancer mortality with a dismal 2β5 % 5-year survival rate. Monotherapy with Gemcitabine has limited success, highlighting the need for additional therapies that enhance the efficacy of current treatments. We evaluated the combination of Gemcitabine and Rosiglitazone, an FDA-approved drug for the treatment of type II diabetes, in an immunocompetent transplantable mouse model of pancreatic cancer. Tumor progression, survival, and metastases were evaluated in immunocompetent mice with subcutaneous or orthotopic pancreatic tumors treated with Pioglitazone, Rosiglitazone, Gemcitabine, or combinations of these. We characterized the impact of high-dose Rosiglitazone and Gemcitabine therapy on immune suppressive mediators, including MDSC and T regulatory cells, and on modulation of peripheral and intra-tumoral T cell populations. Combinations of Rosiglitazone and Gemcitabine significantly reduced tumor progression and metastases, enhanced apoptosis, and significantly extended overall survival compared to Gemcitabine alone. Rosiglitazone altered tumor-associated immune suppressive mediators by limiting early MDSC accumulation and intra-tumoral T regulatory cells. Combination therapy with Rosiglitazone and Gemcitabine modulated T cell populations by enhancing circulating CD8+ T cells and intra-tumoral CD4+ and CD8+ T cells while limiting T regulatory cells. The results suggest that Rosiglitazone, in combination with Gemcitabine, decreases immune suppressive mechanisms in immunocompetent animals and provides pre-clinical data in support of combining Rosiglitazone and Gemcitabine as a clinical therapy for pancreatic cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {π}
- Health & Fitness
- Science
- Education
Content Management System {π}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of link.springer.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {πΈ}
We're unsure how the site profits.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {π}
cancer, article, google, scholar, pubmed, cas, pancreatic, cells, rosiglitazone, gemcitabine, cell, peroxisome, proliferatoractivated, res, receptor, growth, tumor, gamma, bailey, hollingsworth, diabetes, regulatory, access, clin, combination, immune, progression, mice, mol, privacy, cookies, content, pioglitazone, therapy, immunol, chen, ppargamma, ligands, inhibit, data, publish, research, search, immunology, immunotherapy, reduces, suppression, populations, bunt, mohr,
Topics {βοΈ}
peroxisome proliferator-activated receptor-gamma 1-bis[3β²-indolyl]-1-[p-substitutedphenyl]methanes peroxisome-proliferator-activated receptors month download article/chapter myeloid-derived suppressor cells nested case-control study ppargamma-independent signal pathways transforming growth factor-beta1 steroidal anti-inflammatory drugs nonsteroidal anti-inflammatory drugs prostate-specific antigen expression full article pdf related subjects article cancer immunology spontaneous pancreatic carcinoma cancer cell growth privacy choices/manage cookies rna interference suppression ppargamma independent mechanisms santos-gallego cg nci training grant pancreatic ductal adenocarcinoma tumor-bearing mice human pancreatic carcinomas bladder tumor growth pancreatic cancer cells human prostate cancer pancreatic tumour cells anti-cancer agent induce cell death cell activation induced resected pancreatic cancer pancreatic cancer development advanced pancreatic cancer unmc histology facility reactive tumor microenvironment facilitate tumor progression inflammatory mechanisms contributing nuclear factor-kappab unmc comparative medicine rosiglitazone altered tumor epithelial inflammatory response vivo glioma growth european economic area fda-approved drug immune suppressive mediators teff/treg ratio plasminogen activator system koeffler hp cd3/cd28 costimulation
Questions {β}
- Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer
description:Pancreatic ductal adenocarcinoma is a leading cause of cancer mortality with a dismal 2β5Β % 5-year survival rate. Monotherapy with Gemcitabine has limited success, highlighting the need for additional therapies that enhance the efficacy of current treatments. We evaluated the combination of Gemcitabine and Rosiglitazone, an FDA-approved drug for the treatment of type II diabetes, in an immunocompetent transplantable mouse model of pancreatic cancer. Tumor progression, survival, and metastases were evaluated in immunocompetent mice with subcutaneous or orthotopic pancreatic tumors treated with Pioglitazone, Rosiglitazone, Gemcitabine, or combinations of these. We characterized the impact of high-dose Rosiglitazone and Gemcitabine therapy on immune suppressive mediators, including MDSC and T regulatory cells, and on modulation of peripheral and intra-tumoral T cell populations. Combinations of Rosiglitazone and Gemcitabine significantly reduced tumor progression and metastases, enhanced apoptosis, and significantly extended overall survival compared to Gemcitabine alone. Rosiglitazone altered tumor-associated immune suppressive mediators by limiting early MDSC accumulation and intra-tumoral T regulatory cells. Combination therapy with Rosiglitazone and Gemcitabine modulated T cell populations by enhancing circulating CD8+ T cells and intra-tumoral CD4+ and CD8+ T cells while limiting T regulatory cells. The results suggest that Rosiglitazone, in combination with Gemcitabine, decreases immune suppressive mechanisms in immunocompetent animals and provides pre-clinical data in support of combining Rosiglitazone and Gemcitabine as a clinical therapy for pancreatic cancer.
datePublished:2012-08-05T00:00:00Z
dateModified:2012-08-05T00:00:00Z
pageStart:225
pageEnd:236
sameAs:https://doi.org/10.1007/s00262-012-1324-3
keywords:
PPARΞ³
Pancreas cancer
Rosiglitazone
T regulatory cells
Gemcitabine
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig4_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:62
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Stephanie K. Bunt
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Ashley M. Mohr
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Jennifer M. Bailey
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Paul M. Grandgenett
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Michael A. Hollingsworth
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer
description:Pancreatic ductal adenocarcinoma is a leading cause of cancer mortality with a dismal 2β5Β % 5-year survival rate. Monotherapy with Gemcitabine has limited success, highlighting the need for additional therapies that enhance the efficacy of current treatments. We evaluated the combination of Gemcitabine and Rosiglitazone, an FDA-approved drug for the treatment of type II diabetes, in an immunocompetent transplantable mouse model of pancreatic cancer. Tumor progression, survival, and metastases were evaluated in immunocompetent mice with subcutaneous or orthotopic pancreatic tumors treated with Pioglitazone, Rosiglitazone, Gemcitabine, or combinations of these. We characterized the impact of high-dose Rosiglitazone and Gemcitabine therapy on immune suppressive mediators, including MDSC and T regulatory cells, and on modulation of peripheral and intra-tumoral T cell populations. Combinations of Rosiglitazone and Gemcitabine significantly reduced tumor progression and metastases, enhanced apoptosis, and significantly extended overall survival compared to Gemcitabine alone. Rosiglitazone altered tumor-associated immune suppressive mediators by limiting early MDSC accumulation and intra-tumoral T regulatory cells. Combination therapy with Rosiglitazone and Gemcitabine modulated T cell populations by enhancing circulating CD8+ T cells and intra-tumoral CD4+ and CD8+ T cells while limiting T regulatory cells. The results suggest that Rosiglitazone, in combination with Gemcitabine, decreases immune suppressive mechanisms in immunocompetent animals and provides pre-clinical data in support of combining Rosiglitazone and Gemcitabine as a clinical therapy for pancreatic cancer.
datePublished:2012-08-05T00:00:00Z
dateModified:2012-08-05T00:00:00Z
pageStart:225
pageEnd:236
sameAs:https://doi.org/10.1007/s00262-012-1324-3
keywords:
PPARΞ³
Pancreas cancer
Rosiglitazone
T regulatory cells
Gemcitabine
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1324-3/MediaObjects/262_2012_1324_Fig4_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:62
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Stephanie K. Bunt
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Ashley M. Mohr
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Jennifer M. Bailey
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Paul M. Grandgenett
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
type:Person
name:Michael A. Hollingsworth
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:62
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Stephanie K. Bunt
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
name:Ashley M. Mohr
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
name:Jennifer M. Bailey
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
name:Paul M. Grandgenett
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
name:Michael A. Hollingsworth
affiliation:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center
address:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
name:Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(155)
- What's the profit of https://www.springernature.com/gp/authors?
- How much revenue does https://link.springernature.com/home/ generate?
- How much does https://order.springer.com/public/cart bring in each month?
- What's the income of https://submission.nature.com/new-submission/262/3 ?
- How much profit does https://www.springernature.com/gp/librarians/licensing/agc/journals generate?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-06-0369 gross monthly?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17000676's earnings
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Prevalence%20of%20FOXP3%2B%20regulatory%20T%20cells%20increases%20during%20the%20progression%20of%20pancreatic%20ductal%20adenocarcinoma%20and%20its%20premalignant%20lesions&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0369&volume=12&pages=5423-5434&publication_year=2006&author=Hiraoka%2CN&author=Onozato%2CK&author=Kosuge%2CT&author=Hirohashi%2CS is on a monthly basis
- What are the earnings of https://doi.org/10.1111%2Fj.1365-2567.2009.03105.x?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19689743
- How much does http://scholar.google.com/scholar_lookup?&title=Increase%20in%20frequency%20of%20myeloid-derived%20suppressor%20cells%20in%20mice%20with%20spontaneous%20pancreatic%20carcinoma&journal=Immunology&doi=10.1111%2Fj.1365-2567.2009.03105.x&volume=128&pages=141-149&publication_year=2009&author=Zhao%2CF&author=Obermann%2CS&author=Wasielewski%2CR&author=Haile%2CL&author=Manns%2CMP&author=Korangy%2CF&author=Greten%2CT earn?
- What's the income generated by https://doi.org/10.4049%2Fjimmunol.0804322 each month?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19109152
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Progression%20of%20pancreatic%20adenocarcinoma%20is%20significantly%20impeded%20with%20a%20combination%20of%20vaccine%20and%20COX-2%20inhibition&journal=J%20Immunol&doi=10.4049%2Fjimmunol.0804322&volume=182&pages=216-224&publication_year=2009&author=Mukherjee%2CP&author=Basu%2CGD&author=Tinder%2CTL&author=Subramani%2CDB&author=Bradley%2CJM&author=Arefayene%2CM&author=Skaar%2CT&author=De%20petris%2CG
- What's the monthly money flow for https://doi.org/10.1016%2Fj.intimp.2009.03.015?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19336265 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Gemcitabine%20directly%20inhibits%20myeloid%20derived%20suppressor%20cells%20in%20BALB%2Fc%20mice%20bearing%204T1%20mammary%20carcinoma%20and%20augments%20expansion%20of%20T%20cells%20from%20tumor-bearing%20mice&journal=Int%20Immunopharmacol&doi=10.1016%2Fj.intimp.2009.03.015&volume=9&pages=900-909&publication_year=2009&author=Le%2CHK&author=Graham%2CL&author=Cha%2CE&author=Morales%2CJK&author=Manjili%2CMH&author=Bear%2CHD generate monthly?
- Explore the financials of https://doi.org/10.1038%2F2030
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9734398 make?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Differentiation%20and%20reversal%20of%20malignant%20changes%20in%20colon%20cancer%20through%20PPARgamma&journal=Nat%20Med&doi=10.1038%2F2030&volume=4&pages=1046-1052&publication_year=1998&author=Sarraf%2CP&author=Mueller%2CE&author=Jones%2CD&author=King%2CFJ&author=DeAngelo%2CDJ&author=Partridge%2CJB&author=Holden%2CSA&author=Chen%2CLB&author=Fletcher%2CC&author=Spiegelman%2CBM
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12538445's total income per month
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Peroxisome%20proliferator-activated%20receptor%20gamma%20and%20cancers&journal=Clin%20Cancer%20Res&volume=9&pages=1-9&publication_year=2003&author=Koeffler%2CHP?
- How profitable is https://doi.org/10.1002%2Fijc.1488?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11745416 make?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Ligands%20for%20peroxisome%20proliferator-activated%20receptor%20gamma%20inhibit%20growth%20of%20pancreatic%20cancers%20both%20in%20vitro%20and%20in%20vivo&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.1488&volume=94&pages=370-376&publication_year=2001&author=Itami%2CA&author=Watanabe%2CG&author=Shimada%2CY&author=Hashimoto%2CY&author=Kawamura%2CJ&author=Kato%2CM
- What's the financial gain of https://doi.org/10.1124%2Fmol.106.022194?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16887936 earns monthly
- What's the income of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20in%20vivo%20glioma%20growth%20and%20invasion%20by%20peroxisome%20proliferator-activated%20receptor%20gamma%20agonist%20treatment&journal=Mol%20Pharmacol&doi=10.1124%2Fmol.106.022194&volume=70&pages=1524-1533&publication_year=2006&author=Grommes%2CC&author=Landreth%2CGE&author=Sastre%2CM&author=Beck%2CM&author=Feinstein%2CDL&author=Jacobs%2CAH&author=Schiegel%2CU&author=Heneka%2CMT?
- How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-05-2755 generate?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16397256 each month?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20bladder%20tumor%20growth%20by%201%2C1-bis%5B3%E2%80%B2-indolyl%5D-1-%5Bp-substitutedphenyl%5Dmethanes%3A%20a%20new%20class%20of%20peroxisome%20proliferator-activated%20receptor%20gamma%20agonists&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-2755&volume=66&pages=412-418&publication_year=2006&author=Kassouf%2CW&author=Chintharlapalli%2CS&author=Abdelrahim%2CM&author=Nelkin%2CG&author=Safe%2CS&author=Kamat%2CAM?
- What is the monthly revenue of https://doi.org/10.1158%2F1541-7786.MCR-05-0257?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16547153
- http://scholar.google.com/scholar_lookup?&title=Activation%20of%20peroxisome%20proliferator-activated%20receptor-gamma%20decreases%20pancreatic%20cancer%20cell%20invasion%20through%20modulation%20of%20the%20plasminogen%20activator%20system&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-05-0257&volume=4&pages=159-167&publication_year=2006&author=Sawai%2CH&author=Liu%2CJ&author=Reber%2CHA&author=Hines%2COJ&author=Eibl%2CG's revenue stream
- What's the income of https://doi.org/10.1111%2Fj.1365-2567.2008.02849.x?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18422969 bring in?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Toll-like%20receptor%204%20mediates%20cross-talk%20between%20peroxisome%20proliferator-activated%20receptor%20gamma%20and%20nuclear%20factor-kappaB%20in%20macrophages&journal=Immunology&doi=10.1111%2Fj.1365-2567.2008.02849.x&volume=125&pages=344-358&publication_year=2008&author=Necela%2CBM&author=Su%2CW&author=Thompson%2CEA?
- How much does https://doi.org/10.1172%2FJCI7145 pull in monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10449430 have monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=A%20novel%20therapy%20for%20colitis%20utilizing%20PPAR-gamma%20ligands%20to%20inhibit%20the%20epithelial%20inflammatory%20response&journal=J%20Clin%20Invest&doi=10.1172%2FJCI7145&volume=104&pages=383-389&publication_year=1999&author=Su%2CCG&author=Wen%2CX&author=Bailey%2CST&author=Jiang%2CW&author=Rangwala%2CSM&author=Keilbaugh%2CSA&author=Flanigan%2CA&author=Murthy%2CS&author=Lazar%2CMA&author=Wu%2CGD?
- Financial intake of https://doi.org/10.1200%2FJCO.2006.07.2777
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17442990's earnings
- http://scholar.google.com/scholar_lookup?&title=Thiazolidinediones%20and%20the%20risk%20of%20lung%2C%20prostate%2C%20and%20colon%20cancer%20in%20patients%20with%20diabetes&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.07.2777&volume=25&pages=1476-1481&publication_year=2007&author=Govindarajan%2CR&author=Ratnasinghe%2CL&author=Simmons%2CDL&author=Siegel%2CER&author=Midathada%2CMV&author=Kim%2CL&author=Kim%2CPJ&author=Owens%2CRJ&author=Lang%2CNP's financial summary
- How much money does https://doi.org/10.2337%2Fdc07-2308 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18375416 earn?
- Profit of http://scholar.google.com/scholar_lookup?&title=Rosiglitazone%20and%20risk%20of%20cancer%3A%20a%20meta-analysis%20of%20randomized%20clinical%20trials&journal=Diabetes%20Care&doi=10.2337%2Fdc07-2308&volume=31&pages=1455-1460&publication_year=2008&author=Monami%2CM&author=Lamanna%2CC&author=Marchionni%2CN&author=Mannucci%2CE
- Financial intake of https://doi.org/10.1073%2Fpnas.96.7.3951
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10097144?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Induction%20of%20solid%20tumor%20differentiation%20by%20the%20peroxisome%20proliferator-activated%20receptor-gamma%20ligand%20troglitazone%20in%20patients%20with%20liposarcoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.96.7.3951&volume=96&pages=3951-3956&publication_year=1999&author=Demetri%2CGD&author=Fletcher%2CCD&author=Mueller%2CE&author=Sarraf%2CP&author=Naujoks%2CR&author=Campbell%2CN&author=Spiegelman%2CBM&author=Singer%2CS have monthly?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11034093
- What's http://scholar.google.com/scholar_lookup?&title=Down-Regulation%20of%20prostate-specific%20antigen%20expression%20by%20ligands%20for%20peroxisome%20proliferator-activated%20receptor%20gamma%20in%20human%20prostate%20cancer&journal=Cancer%20Res&volume=60&pages=5494-5498&publication_year=2000&author=Hisatake%2CJI&author=Ikezoe%2CT&author=Carey%2CM&author=Holden%2CS&author=Tomoyasu%2CS&author=Koeffler%2CHP's gross income?
- What's the financial gain of https://doi.org/10.1111%2Fj.1582-4934.2010.01083.x?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20455996?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=The%20impact%20of%20type%202%20diabetes%20and%20antidiabetic%20drugs%20on%20cancer%20cell%20growth&journal=J%20Cell%20Mol%20Med&doi=10.1111%2Fj.1582-4934.2010.01083.x&volume=15&pages=825-836&publication_year=2011&author=Feng%2CYH&author=Velazquez-Torres%2CG&author=Gully%2CC&author=Chen%2CJ&author=Lee%2CMH&author=Yeung%2CSC?
- How much does https://doi.org/10.1016%2Fj.clpt.2003.11.231 gross monthly?
- http://scholar.google.com/scholar_lookup?&title=Rosiglitazone%20works%20synergistically%20with%20Gemcitabine%20to%20induce%20cell%20death%20in%20pancreas%20cancer%20cell%20lines&journal=Clin%20Pharmacol%20Ther&doi=10.1016%2Fj.clpt.2003.11.231&volume=75&publication_year=2004&author=Salesiotis%2CAN&author=Laguinge%2CL&author=Ling%2CS&author=Marshall%2CJ&author=Jessup%2CJM's financial summary
- How much profit does https://doi.org/10.3748%2Fwjg.13.6385 make?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17461445?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Rosiglitazone%20enhances%20fluorouracil-induced%20apoptosis%20of%20HT-29%20cells%20by%20activating%20peroxisome%20proliferator-activated%20receptor%20gamma&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.13.6385&volume=13&pages=1534-1540&publication_year=2007&author=Zhang%2CYQ&author=Tang%2CXQ&author=Sun%2CL&author=Dong%2CL&author=Qin%2CY&author=Liu%2CHQ&author=Xia%2CH&author=Cao%2CJG generate?
- How much does https://doi.org/10.1038%2Fnri912 pull in?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12360213
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Emerging%20roles%20of%20PPARs%20in%20inflammation%20and%20immunity&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fnri912&volume=2&pages=748-759&publication_year=2002&author=Daynes%2CRA&author=Jones%2CDC?
- What is the earnings of https://doi.org/10.1182%2Fblood-2005-09-3777?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16527895 make?
- How much income does http://scholar.google.com/scholar_lookup?&title=Peroxisome%20proliferator-activated%20receptor%20gamma%20%5BPPARgamma%5D%20ligands%20reverse%20CTL%20suppression%20by%20alternatively%20activated%20%5BM2%5D%20macrophages%20in%20cancer&journal=Blood&doi=10.1182%2Fblood-2005-09-3777&volume=108&pages=525-535&publication_year=2006&author=Ginderachter%2CJA&author=Meerschaut%2CS&author=Liu%2CY&author=Brys%2CL&author=Groeve%2CK&author=Hassanzadeh%20Ghassabeh%2CG&author=Geert%2CR&author=Baetselier%2CP have?
- Get to know https://doi.org/10.1038%2Fonc.2009.220's earnings
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19633682 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Sonic%20hedgehog%20paracrine%20signaling%20regulates%20metastasis%20and%20lymphangiogenesis%20in%20pancreatic%20cancer&journal=Oncogene&doi=10.1038%2Fonc.2009.220&volume=28&pages=3513-3525&publication_year=2009&author=Bailey%2CJM&author=Mohr%2CAM&author=Hollingsworth%2CMA generate monthly?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-05-1197 bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16707592 generate monthly?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=RNA%20interference%20suppression%20of%20MUC1%20reduces%20the%20growth%20rate%20and%20metastatic%20phenotype%20of%20human%20pancreatic%20cancer%20cells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-1197&volume=12&pages=2976-2987&publication_year=2006&author=Tsutsumida%2CH&author=Swanson%2CBJ&author=Singh%2CPK&author=Caffrey%2CTC&author=Kitajima%2CS&author=Goto%2CM&author=Yonezawa%2CS&author=Hollingsworth%2CMA?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=The%20reactive%20tumor%20microenvironment%3A%20MUC1%20signaling%20directly%20reprograms%20transcription%20of%20CTGF&journal=Oncogene&volume=29&pages=5667-5677&publication_year=2101&author=Behrens%2CME&author=Grandgenett%2CPM&author=Bailey%2CJM&author=Singh%2CPK&author=Yi%2CCH&author=Yu%2CF&author=Hollingsworth%2CMA?
- How much does https://doi.org/10.1074%2Fjbc.M805036200 net monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18625714
- Earnings of http://scholar.google.com/scholar_lookup?&title=Phosphorylation%20of%20MUC1%20by%20Met%20modulates%20interaction%20with%20p53%20and%20MMP1%20expression&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M805036200&volume=283&pages=26985-26995&publication_year=2008&author=Singh%2CPK&author=Behrens%2CME&author=Eggers%2CJP&author=Cerny%2CRL&author=Bailey%2CJM&author=Shanmugam%2CK&author=Gendler%2CSJ&author=Bennett%2CEP&author=Hollingsworth%2CMA
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10878351 generate?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Gr-1%2B%20myeloid%20cells%20derived%20from%20tumor-bearing%20mice%20inhibit%20primary%20T%20cell%20activation%20induced%20through%20CD3%2FCD28%20costimulation&journal=J%20Immunol&volume=165&pages=779-785&publication_year=2000&author=Kusmartsev%2CSA&author=Li%2CY&author=Chen%2CSH?
- How much profit does https://doi.org/10.1136%2Fgut.2003.031997 make?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15479693
- What's the income of http://scholar.google.com/scholar_lookup?&title=Antidiabetic%20thiazolidinediones%20inhibit%20invasiveness%20of%20pancreatic%20cancer%20cells%20via%20PPARgamma%20independent%20mechanisms&journal=Gut&doi=10.1136%2Fgut.2003.031997&volume=53&pages=1688-1697&publication_year=2004&author=Galli%2CA&author=Ceni%2CE&author=Crabb%2CDW&author=Mello%2CT&author=Salzano%2CR&author=Grappone%2CC&author=Milani%2CS&author=Surrenti%2CE&author=Surrenti%2CC&author=Casini%2CA?
- How much revenue does https://doi.org/10.1038%2Fnrc1254 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14708026 gross monthly?
- http://scholar.google.com/scholar_lookup?&title=Peroxisome-proliferator-activated%20receptors%20and%20cancers%3A%20complex%20stories&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1254&volume=4&pages=61-70&publication_year=2004&author=Michalik%2CL&author=Desvergne%2CB&author=Wahli%2CW's revenue stream
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16365420
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Inflammation%20induces%20myeloid-derived%20suppressor%20cells%20that%20facilitate%20tumor%20progression&journal=J%20Immunol&volume=176&pages=284-290&publication_year=2006&author=Bunt%2CSK&author=Sinha%2CP&author=Clements%2CVK&author=Leips%2CJ&author=Ostrand-Rosenberg%2CS?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Inflammatory%20mechanisms%20contributing%20to%20pancreatic%20cancer%20development&journal=Ann%20Surg&volume=239&pages=763-769&publication_year=2004&author=Farrow%2CB&author=Sugiyama%2CY&author=Chen%2CA&author=Uffort%2CE&author=Nealon%2CW&author=Mark%20Evers%2CB
- Get to know https://doi.org/10.1158%2F1535-7163.MCT-05-0347's earnings
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16505118's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=Rosiglitazone%20suppresses%20human%20lung%20carcinoma%20cell%20growth%20through%20PPARgamma-dependent%20and%20PPARgamma-independent%20signal%20pathways&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-05-0347&volume=5&pages=430-437&publication_year=2006&author=Han%2CS&author=Roman%2CJ net monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12370270?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=PPARgamma%20ligands%20inhibit%20primary%20tumor%20growth%20and%20metastasis%20by%20inhibiting%20angiogenesis&journal=J%20Clin%20Invest&volume=110&pages=923-932&publication_year=2002&author=Panigrahy%2CD&author=Singer%2CS&author=Shen%2CLQ&author=Butterfield%2CCE&author=Freedman%2CDA&author=Chen%2CEJ&author=Moses%2CMA&author=Kilroy%2CS&author=Duensing%2CS&author=Fletcher%2CC&author=Fletcher%2CJA&author=Hlatky%2CL
- Explore the financials of https://doi.org/10.1038%2Fsj.bjc.6605636
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20372155?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Non-steroidal%20anti-inflammatory%20drugs%20and%20pancreatic%20cancer%20risk%3A%20a%20nested%20case-control%20study&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6605636&volume=102&pages=1415-1421&publication_year=2010&author=Bradley%2CMC&author=Hughes%2CCM&author=Cantwell%2CMM&author=Napolitano%2CG&author=Murray%2CLJ?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10485483 have?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Increased%20cyclooxygenase-2%20expression%20in%20human%20pancreatic%20carcinomas%20and%20cell%20lines%3A%20growth%20inhibition%20by%20nonsteroidal%20anti-inflammatory%20drugs&journal=Cancer%20Res&volume=59&pages=4356-4362&publication_year=1999&author=Molina%2CMA&author=Sitja-Arnau%2CM&author=Lemoine%2CMG&author=Frazier%2CML&author=Sinicrope%2CFA
- How much revenue does https://doi.org/10.1097%2FMPA.0b013e318172b4dd generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18815538's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Effect%20of%20celecoxib%20and%20the%20novel%20anti-cancer%20agent%2C%20dimethylamino-parthenolide%2C%20in%20a%20developmental%20model%20of%20pancreatic%20cancer&journal=Pancreas&doi=10.1097%2FMPA.0b013e318172b4dd&volume=37&pages=e45-e53&publication_year=2008&author=Yip-Schneider%2CMT&author=Wu%2CH&author=Njoku%2CV&author=Ralstin%2CM&author=Holcomb%2CB&author=Crooks%2CPA&author=Neelakantan%2CS&author=Sweeney%2CCJ&author=Schmidt%2CCM pull in monthly?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16151811 each month?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Gemcitabine%20plus%20celecoxib%20%5BGECO%5D%20in%20advanced%20pancreatic%20cancer%3A%20a%20phase%20II%20trial&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-005-0028-1&volume=57&pages=185-190&publication_year=2006&author=Ferrari%2CV&author=Valcamonico%2CF&author=Amoroso%2CV&author=Simoncini%2CE&author=Vassalli%2CL&author=Marpicati%2CP&author=Pangoni%2CG&author=Grisanti%2CS&author=Tiberio%2CGA&author=Nodari%2CF&author=Strina%2CC&author=Marini%2CG is on a monthly basis
- https://doi.org/10.1158%2F0008-5472.CAN-06-4174's financial summary
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17483367?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Prostaglandin%20E2%20promotes%20tumor%20progression%20by%20inducing%20myeloid-derived%20suppressor%20cells&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-4174&volume=67&pages=4507-4513&publication_year=2007&author=Sinha%2CP&author=Clements%2CVK&author=Fulton%2CAM&author=Ostrand-Rosenberg%2CS?
- How much revenue does https://doi.org/10.1016%2FS0140-6736%2800%2904046-0 bring in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11229684 make?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Inflammation%20and%20cancer%3A%20back%20to%20Virchow%3F&journal=Lancet&doi=10.1016%2FS0140-6736%2800%2904046-0&volume=357&pages=539-545&publication_year=2001&author=Balkwill%2CF&author=Mantovani%2CA?
- Earnings of https://doi.org/10.1189%2Fjlb.0605341
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16501055?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20the%20peroxisome%20proliferator-activated%20receptor-alpha%20%5BPPAR-alpha%5D%20in%20the%20regulation%20of%20acute%20inflammation&journal=J%20Leukoc%20Biol&doi=10.1189%2Fjlb.0605341&volume=79&pages=999-1010&publication_year=2006&author=Cuzzocrea%2CS&author=Mazzon%2CE&author=Paola%2CR&author=Peli%2CA&author=Bonato%2CA&author=Britti%2CD&author=Genovese%2CT&author=Mula%2CC&author=Crisafulli%2CC&author=Caputi%2CAP
- What's the income generated by https://doi.org/10.1124%2Fmol.106.033357 each month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17412838's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Pioglitazone%20and%20rosiglitazone%20decrease%20prostaglandin%20E2%20in%20non-small-cell%20lung%20cancer%20cells%20by%20up-regulating%2015-hydroxyprostaglandin%20dehydrogenase&journal=Mol%20Pharmacol&doi=10.1124%2Fmol.106.033357&volume=71&pages=1715-1720&publication_year=2007&author=Hazra%2CS&author=Batra%2CRK&author=Tai%2CHH&author=Sharma%2CS&author=Cui%2CX&author=Dubinett%2CSM generate monthly?
- https://doi.org/10.1097%2FCJI.0b013e31818ac2f7's total income per month
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19307990?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=The%20immune%20tolerance%20of%20cancer%20is%20mediated%20by%20IDO%20that%20is%20inhibited%20by%20COX-2%20inhibitors%20through%20regulatory%20T%20cells&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e31818ac2f7&volume=32&pages=22-28&publication_year=2009&author=Lee%2CSY&author=Choi%2CHK&author=Lee%2CKJ&author=Jung%2CJY&author=Hur%2CGY&author=Jung%2CKH&author=Kim%2CJH&author=Shin%2CC&author=Shim%2CJJ&author=In%2CKH&author=Kang%2CKH&author=Yoo%2CSH?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12556242 have monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=The%20relationship%20between%20diabetes%20and%20pancreatic%20cancer&journal=Mol%20Cancer&doi=10.1186%2F1476-4598-2-4&volume=2&publication_year=2003&author=Wang%2CF&author=Herrington%2CM&author=Larsson%2CJ&author=Permert%2CJ?
- Get to know what's the income of https://doi.org/10.1016%2Fj.bbrc.2004.08.151
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15381068 makes per month
- Revenue of http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20the%20effects%20of%20pioglitazone%20and%20rosiglitazone%20on%20macrophage%20foam%20cell%20formation&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2004.08.151&volume=323&pages=782-788&publication_year=2004&author=Hirakata%2CM&author=Tozawa%2CR&author=Imura%2CY&author=Sugiyama%2CY
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18758684
- http://scholar.google.com/scholar_lookup?&title=Effect%20of%20pioglitazone%20and%20rosiglitazone%20on%20mediators%20of%20endothelial%20dysfunction%2C%20markers%20of%20angiogenesis%20and%20inflammatory%20cytokines%20in%20type-2%20diabetes&journal=Acta%20Diabetol&doi=10.1007%2Fs00592-008-0054-7&volume=46&pages=27-33&publication_year=2009&author=Vijay%2CSK&author=Mishra%2CM&author=Kumar%2CH&author=Tripathi%2CK income
- Check the income stats for https://doi.org/10.2337%2Fdiabetes.54.3.811
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15734860 generate?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Pioglitazone%20induces%20vascular%20smooth%20muscle%20cell%20apoptosis%20through%20a%20peroxisome%20proliferator-activated%20receptor-gamma%2C%20transforming%20growth%20factor-beta1%2C%20and%20a%20Smad2-dependent%20mechanism&journal=Diabetes&doi=10.2337%2Fdiabetes.54.3.811&volume=54&pages=811-817&publication_year=2005&author=Redondo%2CS&author=Ruiz%2CE&author=Santos-Gallego%2CCG&author=Padilla%2CE&author=Tejerina%2CT?
- How much profit does https://citation-needed.springer.com/v2/references/10.1007/s00262-012-1324-3?format=refman&flavour=references make?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stephanie%20K.%20Bunt generate?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stephanie%20K.%20Bunt%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ashley%20M.%20Mohr
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ashley%20M.%20Mohr%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jennifer%20M.%20Bailey generate monthly?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jennifer%20M.%20Bailey%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Paul%20M.%20Grandgenett earning monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Paul%20M.%20Grandgenett%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20A.%20Hollingsworth generate?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20A.%20Hollingsworth%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- What's the revenue for https://s100.copyright.com/AppDispatchServlet?title=Rosiglitazone%20and%20Gemcitabine%20in%20combination%20reduces%20immune%20suppression%20and%20modulates%20T%20cell%20populations%20in%20pancreatic%20cancer&author=Stephanie%20K.%20Bunt%20et%20al&contentID=10.1007%2Fs00262-012-1324-3©right=Springer-Verlag&publication=0340-7004&publicationDate=2012-08-05&publisherName=SpringerNature&orderBeanReset=true?
- What's the revenue for https://citation-needed.springer.com/v2/references/10.1007/s00262-012-1324-3?format=refman&flavour=citation?
- What's the monthly income of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research pull in monthly?
- How much money does https://www.springernature.com/gp/products generate?
- How much income does https://www.springernature.com/gp/librarians have?
- How much does https://www.springernature.com/gp/societies pull in?
- Income figures for https://www.springernature.com/gp/partners
- What's https://www.springer.com/'s gross income?
- How much does https://www.nature.com/ rake in every month?
- How much cash flow does https://www.biomedcentral.com/ have monthly?
- Find out how much https://www.palgrave.com/ earns monthly
- What's the monthly money flow for https://www.apress.com/?
- https://www.springernature.com/gp/legal/ccpa's total income per month
- How much profit does https://www.springernature.com/gp/info/accessibility make?
- What's the monthly money flow for https://support.springernature.com/en/support/home?
- Discover the revenue of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- Financial intake of https://www.springernature.com/
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js
CDN Services {π¦}
- Crossref